Changing behavior isn’t easy, but Dr. Dori Rosenberg helped older people to stand and walk more.
$40.5M NIH-funded project aims to pinpoint cells at root of brain disease—and new therapeutic targets.
Dr. Mike Jackson has long studied the spread of flu and effectiveness of vaccination at Kaiser Permanente Washington. And now… of COVID-19 too.
Katie Coleman describes how the COVID-19 pandemic ushered in a new normal at Kaiser Permanente Washington and how research is vital to making it thrive.
A new open-access peer-reviewed site will explore how best to bring innovations into practice in treating mental illness, substance use, and addictions.